James A. Mastrianni

James Mastrianni practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

James Mastrianni's NPI, 1821149808, was assigned on January 16, 2007. James Mastrianni holds Illinois license 036099006.

James Mastrianni's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

James Mastrianni's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. James Mastrianni is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links James Mastrianni to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Mastrianni practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is James Mastrianni's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. James Mastrianni is licensed in Illinois.

CMS data shows 332 Medicare services from James Mastrianni across 3 procedure codes in 2024, for 250 Medicare patients. Medicare paid $42,513 for them.

CMS counts 250 Medicare patients who saw James Mastrianni in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts James Mastrianni's median patient age at 78, with 58% women.

In 2024, James Mastrianni wrote 1,018 Medicare Part D claims for 253 patients. 95% of them were for generic drugs. CMS names the drug for 929 of them, across 16 drugs with 11 or more claims each, at $36,553 in total drug cost. In 2023, CMS named 781 claims across 14 drugs.

James Mastrianni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Mastrianni as offering telehealth.

Dmand AI links 18 papers to James Mastrianni, published from 2010 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Mice, Transgenic, Prion Diseases and Alzheimer Disease. James Mastrianni has published most often in Front Neurol. James Mastrianni's most frequent co-authors are Kaitlin Seibert, MD, Stephen J. Dearmond, MD and Adil Javed.

Dmand AI links James Mastrianni to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Plaque, Amyloid. AstraZeneca sponsors the most, 2. Open Payments lists research payments to James Mastrianni that name 2 trials.

CMS Open Payments shows 9 general payments to James Mastrianni from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 98% of the total. Ionis Pharmaceuticals, Inc. paid the most, $4,500. It also lists 2 research payments totaling $1,809 from 2018 to 2022, naming 2 clinical trials.